Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome

NCT02636868 is registered in ClinicalTrials.gov with Windtree Therapeutics as lead sponsor.

NCT NCT02636868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02636868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome
Lead sponsor
Windtree Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2015
Completion date
August 6, 2019
Enrollment
221 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory distress syndrome